X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7513) 7513
Magazine Article (22) 22
Book Chapter (15) 15
Dissertation (6) 6
Publication (4) 4
Newsletter (3) 3
Newspaper Article (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5203) 5203
life sciences & biomedicine (5016) 5016
humans (4908) 4908
male (3968) 3968
benzimidazoles - administration & dosage (3158) 3158
animals (3150) 3150
female (2954) 2954
benzimidazoles - therapeutic use (2731) 2731
benzimidazoles - pharmacology (2318) 2318
middle aged (1792) 1792
adult (1505) 1505
pharmacology & pharmacy (1491) 1491
aged (1416) 1416
benzimidazoles - adverse effects (1316) 1316
rats (1312) 1312
administration, oral (1122) 1122
treatment outcome (1078) 1078
dabigatran (1074) 1074
cardiovascular system & cardiology (944) 944
dose-response relationship, drug (873) 873
benzimidazoles - pharmacokinetics (788) 788
mice (787) 787
beta-alanine - analogs & derivatives (771) 771
drug therapy, combination (710) 710
hypertension - drug therapy (698) 698
blood pressure - drug effects (665) 665
abridged index medicus (599) 599
peripheral vascular disease (579) 579
drug therapy (561) 561
double-blind method (558) 558
time factors (558) 558
2-pyridinylmethylsulfinylbenzimidazoles (555) 555
oncology (524) 524
hypertension (511) 511
omeprazole - analogs & derivatives (460) 460
tetrazoles - pharmacology (455) 455
cardiac & cardiovascular systems (446) 446
analysis (439) 439
aged, 80 and over (433) 433
anticoagulants - therapeutic use (432) 432
anticoagulants - administration & dosage (426) 426
rivaroxaban (426) 426
gastroenterology & hepatology (411) 411
research (410) 410
drug administration schedule (405) 405
rats, sprague-dawley (404) 404
medicine & public health (392) 392
general & internal medicine (390) 390
tetrazoles - administration & dosage (389) 389
telmisartan (385) 385
atrial fibrillation - drug therapy (378) 378
benzoates - administration & dosage (373) 373
tetrazoles - therapeutic use (373) 373
adolescent (372) 372
angiotensin ii type 1 receptor blockers - therapeutic use (372) 372
risk factors (366) 366
angiotensin ii type 1 receptor blockers - pharmacology (364) 364
medicine, general & internal (364) 364
antihypertensive agents - administration & dosage (363) 363
dosage and administration (362) 362
beta-alanine - therapeutic use (360) 360
benzoates - therapeutic use (359) 359
stroke - prevention & control (351) 351
beta-alanine - administration & dosage (349) 349
angiotensin ii type 1 receptor blockers - administration & dosage (348) 348
care and treatment (348) 348
benzimidazoles (347) 347
anticoagulants (345) 345
anticoagulants - adverse effects (341) 341
health aspects (340) 340
antihypertensive agents - therapeutic use (339) 339
beta-alanine - adverse effects (338) 338
disease models, animal (332) 332
rats, wistar (317) 317
neurosciences & neurology (314) 314
benzimidazoles - chemistry (312) 312
angiotensin receptor antagonists (305) 305
atrial fibrillation (305) 305
drug interactions (299) 299
candesartan (297) 297
angiotensin (295) 295
hypertension - physiopathology (294) 294
benzimidazole (292) 292
benzimidazoles - blood (285) 285
internal medicine (284) 284
morpholines - therapeutic use (283) 283
proton pump inhibitors (282) 282
chemistry (281) 281
neurosciences (280) 280
anthelmintics - therapeutic use (271) 271
prospective studies (271) 271
benzoates - pharmacology (270) 270
physical sciences (269) 269
clinical trials (268) 268
thiophenes - therapeutic use (264) 264
anthelmintics - administration & dosage (262) 262
blood pressure (258) 258
pharmacokinetics (258) 258
clinical trials as topic (256) 256
pharmacology/toxicology (255) 255
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7098) 7098
Russian (172) 172
German (156) 156
Japanese (143) 143
French (54) 54
Spanish (48) 48
Chinese (23) 23
Portuguese (18) 18
Italian (16) 16
Polish (16) 16
Czech (15) 15
Dutch (13) 13
Hungarian (10) 10
Swedish (7) 7
Turkish (7) 7
Norwegian (6) 6
Ukrainian (5) 5
Danish (4) 4
Slovak (3) 3
Bulgarian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Croatian (1) 1
Finnish (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of hepatology, ISSN 0168-8278, 12/2015, Volume 63, Issue 6, pp. 1511 - 1522
Summary Failure to respond to the approved combinations of multiple direct-acting antiviral agents is relatively low in hepatitis C virus treatment... 
Gastroenterology and Hepatology | Daclatasvir | Simeprevir | Treatment | Resistance-associated variants | Ledipasvir | Interferon | Hepatitis C virus | Sofosbuvir | Direct-acting antivirals | Resistanceassociated variants | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Uridine Monophosphate - administration & dosage | Humans | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Carbamates - administration & dosage | Simeprevir - administration & dosage | Uracil - administration & dosage | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Treatment Failure | Protease Inhibitors - administration & dosage | Fluorenes - administration & dosage | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Clinical Trials as Topic | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Interferons - administration & dosage | Drug Resistance, Viral - genetics | Anilides - administration & dosage | Sofosbuvir - administration & dosage | Uridine Monophosphate - analogs & derivatives | Macrocyclic Compounds - administration & dosage | Sulfonamides - administration & dosage | Uracil - analogs & derivatives | Development and progression | Protease inhibitors | Drug resistance | Hepatitis C | Proteases | Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 09/2016, Volume 151, Issue 3, pp. 457 - 471.e5
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2014, Volume 64, Issue 11, pp. 1128 - 1139
Journal Article
Journal of hepatology, ISSN 0168-8278, 06/2017, Volume 66, Issue 6, pp. 1138 - 1148
Graphical abstract 
Gastroenterology and Hepatology | Antiviral agents | Ombitasvir | Ritonavir | Ledipasvir | Real-world | Genotype 1 | Paritaprevir | Sustained virologic response | Hepatitis C, Chronic | Sofosbuvir | Dasabuvir | Randomized controlled trials | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepatitis C, Chronic - physiopathology | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Carbamates - administration & dosage | Neoplasm Recurrence, Local - etiology | Liver Neoplasms - etiology | Young Adult | Uracil - administration & dosage | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Drug Therapy, Combination | Glomerular Filtration Rate | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Spain | Anilides - administration & dosage | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Macrocyclic Compounds - administration & dosage | Sustained Virologic Response | Sulfonamides - administration & dosage | Cohort Studies | Uracil - analogs & derivatives | Genetic aspects | Safety and security measures | Hepatitis C virus | Index Medicus
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2014, Volume 179, pp. 279 - 287
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2009, Volume 101, Issue 1, pp. 77 - 85
Dabigatran etexilate has been investigated in three phase III trials for the prevention of venous thromboembolism (VTE). Health technology assessment agencies... 
anticoagulants | thrombosis | prophylaxis | Embolism | Meta-analysis | Anticoagulants | Thrombosis | Prophylaxis | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Humans | Dabigatran | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Clinical Trials, Phase III as Topic | Enoxaparin - administration & dosage | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Benzimidazoles - adverse effects | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Drug Administration Schedule | Risk Assessment | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Venous Thromboembolism - etiology | Hemorrhage - chemically induced | Index Medicus | Administration | Phase III as Topic | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Pyridines/administration & dosage/adverse effects/therapeutic use | Arthroplasty | Replacement | Oral | Clinical Trials | Kirurgi | Knee/adverse effects | Hemorrhage/chemically induced | Venous Thromboembolism/etiology/mortality/prevention & control | Hip/adverse effects | Anticoagulants/administration & dosage/adverse effects/therapeutic use | Surgery | Enoxaparin/administration & dosage/adverse effects/therapeutic use
Journal Article
Stroke (1970), ISSN 1524-4628, 06/2013, Volume 44, Issue 6, pp. 1676 - 1681
Background and Purpose-To estimate the cost-effectiveness of stroke prevention in patients with nonvalvular atrial fibrillation by using novel oral... 
Intracranial hemorrhage | Stroke | Anticoagulation | Markov model | Cost-effectiveness | Atrial fibrillation | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Thiophenes - therapeutic use | Markov Chains | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | United States | Humans | Anticoagulants - economics | Thiophenes - administration & dosage | Warfarin - economics | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Warfarin - administration & dosage | Warfarin - therapeutic use | Dose-Response Relationship, Drug | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - economics | Stroke - epidemiology | Thiophenes - economics | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Stroke - prevention & control | Administration, Oral | Morpholines - administration & dosage | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Models, Statistical | Pyrazoles - economics | Pyrazoles - administration & dosage | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use | Cohort Studies | Index Medicus
Journal Article
10.